Skip to main content

Bank of New York Mellon Corp

Bank

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1390777 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,235,226
-$2,482,522 QoQ
Shares Held
216,525
+0.3% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. VRDN ranks #96 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,235,226 216,525
2025-12-31 $6,717,748 215,866
2025-09-30 $4,254,928 197,170
2025-06-30 $2,691,484 192,524
2025-03-31 $2,671,424 198,177
2024-12-31 $3,767,325 196,522
2024-09-30 $3,886,381 170,830
2024-06-30 $2,714,873 208,676
2024-03-31 $2,659,102 151,862
2023-12-31 $3,262,882 149,811
2023-09-30 $2,119,634 138,177
2023-06-30 $3,379,416 142,052
2023-03-31 $3,552,312 139,635
2022-12-31 $4,456,071 152,553
2022-09-30 $1,851,293 90,263
2022-06-30 $801,569 69,280